- Director, Brain Health and Memory Center, UH Cleveland Medical Center
- Professor, CWRU School of Medicine
Alan Lerner, MD is the Director of the Brain Health and Memory Center in the Neurological Institute at University Hospitals Cleveland Medical Center. Dr. Lerner completed his neurology residency training at University Hospitals-Case Western Reserve University, followed by a two-year fellowship focusing on Alzheimer's disease and other dementias. At that time, there were no medications approved for Alzheimer's Disease, and Neuroimaging was in its infancy. The technological advances in Dementia recognition, diagnosis, and treatment have been amazing. Yet, Dr. Lerner feels we are in the earliest stages of understanding these disorders and how to treat them with specific targeted interventions. As a result, Behavioral Neurology is now one of the most dynamic and growing areas in all of Neurology.
Dr. Lerner has an active research program and is developing the Cleveland Brain Health Initiative. He is the co-director of the newly funded Cleveland Alzheimer's Disease Research Center's clinical core in association with the Cleveland Clinic Foundation and the Louis Stokes VA.
His clinical practice has also focused on the various dementias, including Alzheimer's Disease, frontotemporal dementia, normal pressure hydrocephalus, and treating people with psychiatric and medical comorbidities.
- Alzheimer's Disease
- Attention Deficit Hyperactivity Disorder (ADHD) in Adults
- Behavioral Neurology
- Frontotemporal Dementia
- Higher Cortical Functions
- Neurology - American Board of Psychiatry and Neurology
Fellowship | Geriatric Medicine
Geriatric Medicine - University Hospitals Of Cleveland (1991 - 1993)
Residency | Neurology
Neurology - University Hospitals Of Cleveland (1988 - 1991)
Internship | Internal Medicine
Internal Medicine - Lenox Hill Hospital (1987 - 1988)
Weill Cornell Medical College (1987)
State University Of New York Health Science Center At Brooklyn (1984)
Cornell University (1979)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Alan Lerner did not disclose any Outside Relationships with Industry.